Woven into the future of world-changing technology.

The common thread in deep tech.

Australia’s first and best early stage deep tech venture fund. Backing research since 2000.

Scroll to discover more ↓
Scroll to discover more ↓
arrow-right
[ About Us]

We’re woven into the universities

where Australia’s best research begins,

and connected all the way to the

global market, backing deep-tech and

life-science companies from the lab bench

to impact and exit.

We’re woven into the universities where Australia’s best research begins, and connected all the way to the global market — backing deep-tech and life-science companies from the lab bench to impact and exit.

Three reasons that matter.

We were first

Founded in 2000, Uniseed is Australia’s longest-running venture fund. We know what early stage science looks like before it works and what it takes to help make it successful.

We're inside the labs, and we're early - when early matters

Uniseed is an independent venture investor, owned by the country’s leading research organisations and CSIRO: partners who fund more than 60% of Australia’s research.

And we have the track record

Being early only counts if you’re right. We are experts in deep tech early stage venture, and our methodology works.

Work–Life Balance
70+ Start-Ups
We support the best of the best, helping Australian deep tech from its earliest stage through to global scale.
Team
1000+ Employed
Our capital keeps significant research and commercial talent in Australia, and brings contract research into our university partners, enabling  more innovation.
Purpose-Driven
$1.6 Billion
Uniseed funds have leveraged over $1.6 billion in further external capital for our businesses and university partners.
Growth Mindset
13 Exits
We have 13 exits and 6 additional commercial transactions, plus a significant portfolio of high-performing companies on their way to global scale.
Every company we back starts with a partner

We are embedded in the commercialisation offices of ten of Australia’s largest research organisations, who together lead more than 60% of the nation’s research. These ten organisations are the primary investors in Uniseed's Commercialisation Fund. All our companies come from the labs of the institutions that back us.

Partner Investors

Tightly woven early, connected for the long run.

Most investors arrive once a company looks like a company. We’re there before the start - when a new discovery needs capital and conviction most, and still connected as it grows, scales, and draws in the world’s largest investors.

Explore Our Portfolio
Explore Our Portfolio

[ Two Funds, One Thread ]

We run two funds with two jobs — and two different measures of success.

Contact Us
Contact Us

Commercialisation Fund

Works at the earliest stage, inside the universities, turning research into companies. Returns are one of several measures here, alongside discoveries commercialised, companies formed and real-world impact.

Venture Fund


Backs the strongest of those companies as they develop and scale, focusing on financial return as the measure of success.
We also manage investment funds on behalf of other major investors, including $100m for one of Australia’s largest superannuation funds, UniSuper.

Why this makes us a better investor

The two funds aren’t parallel - they feed each other. By the time a company reaches the Venture Fund, we’ve already backed it through the Commercialisation Fund: we’ve worked the science, tested the market and watched the team perform. When we invest at venture stage, we’re backing a company we’ve already helped de-risk from the inside.

We build the relationships that scale a company.

The same thread that weaves us into a university weaves us outward. We connect our founders to the people, capital and customers a global business needs.

Contact Us
Contact Us
A network that took 25 years to build.

Co-investors, industry experts, experienced operators and the commercialisation offices of our ten partners - introductions that would take a founder years to earn. We have co-invested with over 160 venture funds and partners over the last 10 years alone.

Uniseed is a unique investor in Australia. They're with us from the start, they invest early and with conviction so when it comes to funding they know each opportunity inside-out. Their independent expert due diligence and sound technical judgement provide our IP Commercialisation team real confidence we are backing the right opportunity. And they stay involved with company board, recruitment, strategy and fundraising support, right through to later stage capital raises and exit.
Dean Moss
Chief Executive Officer, UniQuest
Uniseed has played a pivotal role in Diraq's journey from university research to a global quantum computing company. Their deep technology expertise and willingness to back ambitious innovation have helped us accelerate our growth and our mission to become the world's leading provider of quantum computing hardware.
Andrew Dzurak
CEO and Founder, Diraq
I have worked with Uniseed for more than a decade - first as CEO of Hatchtech, whose product Xeglyze was successfully acquired by Dr Reddy’s Laboratories, and more recently as CEO of Kinoxis Therapeutics. The Uniseed team supports companies from their earliest stages and, through its partnership with UniSuper, can continue investing meaningful capital as they progress into clinical development. This long-term support has been invaluable in maintaining momentum and advancing our programs.
Hugh Alsop
CEO, Kinoxis Therapeutics
We had strong research and a great unmet medical need, but required support in developing the clinical pathway and investment case. Uniseed didn't just fund the idea but really helped us work out what a viable investment actually looked like, well before most investors would even take the meeting.
Kathryn Sunn
CEO, Celosia Therapeutics
Woven into the future of world-changing technology.
Everything You Need to Know